These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14582831)

  • 1. Speech recognition and dysarthria: a single subject study of two individuals with profound impairment of speech and motor control.
    Havstam C; Buchholz M; Hartelius L
    Logoped Phoniatr Vocol; 2003; 28(2):81-90. PubMed ID: 14582831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria.
    Fox CM; Boliek CA
    J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic speech recognition and training for severely dysarthric users of assistive technology: the STARDUST project.
    Parker M; Cunningham S; Enderby P; Hawley M; Green P
    Clin Linguist Phon; 2006; 20(2-3):149-56. PubMed ID: 16428231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech, communication and use of augmentative communication in young people with cerebral palsy: the SH&PE population study.
    Cockerill H; Elbourne D; Allen E; Scrutton D; Will E; McNee A; Fairhurst C; Baird G
    Child Care Health Dev; 2014 Mar; 40(2):149-57. PubMed ID: 23656274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A speech-controlled environmental control system for people with severe dysarthria.
    Hawley MS; Enderby P; Green P; Cunningham S; Brownsell S; Carmichael J; Parker M; Hatzis A; O'Neill P; Palmer R
    Med Eng Phys; 2007 Jun; 29(5):586-93. PubMed ID: 17049905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-frequency spectral components in computer recognition of dysarthric speech based on a Mel-cepstral stochastic model.
    Polur PD; Miller GE
    J Rehabil Res Dev; 2005; 42(3):363-71. PubMed ID: 16187248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home trials of a speech synthesizer in severe dysarthria: patterns of use, satisfaction and utility of word prediction.
    Laffont I; Dumas C; Pozzi D; Ruquet M; Tissier AC; Lofaso F; Dizien O
    J Rehabil Med; 2007 May; 39(5):399-404. PubMed ID: 17549332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive dysarthria therapy for younger children with cerebral palsy.
    Pennington L; Roelant E; Thompson V; Robson S; Steen N; Miller N
    Dev Med Child Neurol; 2013 May; 55(5):464-71. PubMed ID: 23441834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards personalized speech synthesis for augmentative and alternative communication.
    Mills T; Bunnell HT; Patel R
    Augment Altern Commun; 2014 Sep; 30(3):226-36. PubMed ID: 25025818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive communication systems for patients with mobility disorders.
    Zimmer CA; Devlin PM; Werner JL; Stamp CV; Bellian KT; Powell DM; Edlich RF
    J Burn Care Rehabil; 1991; 12(4):354-60. PubMed ID: 1834676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication aids for patients with dys/anarthria.
    Lagerman U; Höök O
    Scand J Rehabil Med; 1982; 14(4):155-8. PubMed ID: 6217545
    [No Abstract]   [Full Text] [Related]  

  • 13. DAF as instrumental treatment for dysarthria in progressive supranuclear palsy: a case report.
    Hanson WR; Metter EJ
    J Speech Hear Disord; 1980 May; 45(2):268-76. PubMed ID: 6449631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rehabilitation of communication impairment in dystonia musculorum deformans.
    Shahar E; Nowaczyk M; Tervo RC
    Pediatr Neurol; 1987; 3(2):97-100. PubMed ID: 2977281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of articulatory impairment in a child with spastic dysarthria associated with cerebral palsy.
    Marchant J; McAuliffe MJ; Huckabee ML
    Dev Neurorehabil; 2008; 11(1):81-90. PubMed ID: 17943504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Listener attitudes toward individuals with cerebral palsy who use speech supplementation strategies.
    Hustad KC; Gearhart KJ
    Am J Speech Lang Pathol; 2004 May; 13(2):168-81. PubMed ID: 15198635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy.
    Leary SM; Gilpin P; Lockley L; Rodriguez L; Jarrett L; Stevenson VL
    Clin Rehabil; 2006 Mar; 20(3):228-31. PubMed ID: 16634341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging access technologies for adults with complex communication needs and severe motor impairments: State of the science.
    Koch Fager S; Fried-Oken M; Jakobs T; Beukelman DR
    Augment Altern Commun; 2019 Mar; 35(1):13-25. PubMed ID: 30663899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysarthria in Adults With Cerebral Palsy: Clinical Presentation and Impacts on Communication.
    Schölderle T; Staiger A; Lampe R; Strecker K; Ziegler W
    J Speech Lang Hear Res; 2016 Apr; 59(2):216-29. PubMed ID: 27057824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a speech recognition prototype for speakers with moderate and severe dysarthria: a preliminary report.
    Fager SK; Beukelman DR; Jakobs T; Hosom JP
    Augment Altern Commun; 2010 Dec; 26(4):267-77. PubMed ID: 21091303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.